HRTS vs. GERM

Last updated Jun 4, 2026

HRTS (Tema Obesity & Cardiometabolic ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. HRTS is actively managed, while GERM is passively managed. Over the past year, HRTS returned 20.97% vs 0.00% for GERM. HRTS charges 0.75%/yr vs 0.68%/yr for GERM.

Performance

HRTS vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HRTS

• 1D: 0.51%
• 1M: -0.90%
• YTD: -5.70%
• 6M: -5.48%
• 1Y: 20.97%
• 3Y*: —
• 5Y*: —
• 10Y*: —

GERM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 0.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRTS vs. GERM - Yearly Performance Comparison

	2026 (YTD)	2025	2024
HRTS Tema Obesity & Cardiometabolic ETF	-5.70%	23.93%	-13.69%
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%

HRTS vs. GERM - Sectors Allocation Comparison

Sectors	HRTS	GERM
Healthcare	100.0%	99.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	0.4%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

HRTS vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS

HRTS Risk / Return Rank: 36
HRTS Sharpe Ratio Rank: 37
HRTS Sortino Ratio Rank: 38
HRTS Omega Ratio Rank: 33
HRTS Calmar Ratio Rank: 39
HRTS Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HRTS	GERM	Difference
Sharpe ratio Return per unit of total volatility	1.31	—	—
Sortino ratio Return per unit of downside risk	1.99	—	—
Omega ratio Gain probability vs. loss probability	1.23	—	—
Calmar ratio Return relative to maximum drawdown	1.91	—	—
Martin ratio Return relative to average drawdown	4.83	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HRTS	GERM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.31	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	—	—

Drawdowns

HRTS vs. GERM - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HRTS and GERM.

Drawdown Indicators

	HRTS	GERM	Difference
Max Drawdown Largest peak-to-trough decline	-25.81%	0.00%	-25.81%
Max Drawdown (1Y) Largest decline over 1 year	-11.01%	0.00%	-11.01%
Current Drawdown Current decline from peak	-9.14%	0.00%	-9.14%
Average Drawdown Average peak-to-trough decline	-9.02%	0.00%	-9.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.36%	0.00%	+4.36%

Volatility

HRTS vs. GERM - Volatility Comparison

Tema Obesity & Cardiometabolic ETF (HRTS) has a higher volatility of 4.44% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that HRTS's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HRTS	GERM	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.44%	0.00%	+4.44%
Volatility (6M) Calculated over the trailing 6-month period	11.26%	0.00%	+11.26%
Volatility (1Y) Calculated over the trailing 1-year period	16.03%	0.00%	+16.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.07%	0.00%	+19.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.07%	0.00%	+19.07%

HRTS vs. GERM - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is higher than GERM's 0.68% expense ratio.

Dividends

HRTS vs. GERM - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.42%, while GERM has not paid dividends to shareholders.

Position	TTM	2025	2024
GERM Amplify Treatments, Testing and Advancements ETF	0.00%	0.00%	0.00%
HRTS Tema Obesity & Cardiometabolic ETF	1.42%	1.34%	1.63%

Frequently Asked Questions

Which is riskier, HRTS or GERM?

HRTS has higher volatility (4.44%) compared to GERM (0.00%). In terms of maximum drawdown, HRTS dropped -25.81% vs GERM's 0.00%.

Which ETF is better, HRTS or GERM?

On 1-year performance, HRTS leads with 20.97% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, HRTS or GERM?

Over the 1-year period, HRTS has performed better with a 20.97% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, HRTS or GERM?

GERM is cheaper with a 0.68% expense ratio, compared with 0.75% for HRTS.

Which ETF pays a higher dividend yield, HRTS or GERM?

HRTS has the higher dividend yield at 1.42%, compared with 0.00% for GERM.

What is the main difference between HRTS and GERM?

They also come from different issuers: Tema and Amplify. Their fees differ too: 0.75% for HRTS and 0.68% for GERM.